Cargando…

Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses

The present study aimed to evaluate a previously reported predictive formula of output-limiting symptoms induced by radiofrequency (RF) to determine the efficacy of this neoadjuvant chemoradiation (NACR) and concurrent RF thermal therapy. The present study included 81 consecutive patients with confi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoji, Hisanori, Motegi, Masahiko, Takakusagi, Yosuke, Asao, Takayuki, Kuwano, Hiroyuki, Takahashi, Takeo, Ogoshi, Kyoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355662/ https://www.ncbi.nlm.nih.gov/pubmed/27959450 http://dx.doi.org/10.3892/or.2016.5300

Ejemplares similares

Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer
por: SHOJI, HISANORI, et al.
Publicado: (2016)

A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study
por: Shoji, Hisanori, et al.
Publicado: (2015)

HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer
por: Sato, Hiro, et al.
Publicado: (2014)

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer
por: Zhang, Jin-Liang, et al.
Publicado: (2017)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)
por: Shiba, Shintaro, et al.
Publicado: (2019)

Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
por: Lee, Jeong Won, et al.
Publicado: (2013)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
por: HASEGAWA, MASAHIRO, et al.
Publicado: (2014)

Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy
por: Lee, Yi-Ying, et al.
Publicado: (2017)

Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy
por: Takeda, Yasuhiro, et al.
Publicado: (2018)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
por: Kong, Moonkyoo, et al.
Publicado: (2012)

Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer
por: Wu, Fengpeng, et al.
Publicado: (2020)

Utility of RGNEF in the Prediction of Clinical Prognosis in Patients with Rectal Cancer Receiving Preoperative Concurrent Chemoradiotherapy
por: Chen, Chih-I., et al.
Publicado: (2021)

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
por: Huang, Yi-Jung, et al.
Publicado: (2022)

Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy
por: Li, Nan, et al.
Publicado: (2017)

Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2005)

Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
por: Chen, Wanghua, et al.
Publicado: (2018)

Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2022)

Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin
por: Lachkar, Bouchra, et al.
Publicado: (2018)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
por: Choi, Euncheol, et al.
Publicado: (2016)

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
por: Lee, Hsin-Hua, et al.
Publicado: (2022)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy
por: Chou, Chia-Lin, et al.
Publicado: (2022)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

Bronchopleural Fistula After Concurrent Chemoradiotherapy
por: van de Pas, Jorien M., et al.
Publicado: (2020)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
por: Tokuhara, Katsuji, et al.
Publicado: (2016)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
por: Stuopelytė, Raminta, et al.
Publicado: (2023)

Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy
por: Yamaguchi, Motoko, et al.
Publicado: (2014)

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

Volumetric imaging parameters are significant for predicting the pathological complete response of preoperative concurrent chemoradiotherapy in local advanced rectal cancer
por: Wu, Fengpeng, et al.
Publicado: (2019)

Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy
por: Sun, Yi, et al.
Publicado: (2023)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017)

A novel one-step lens cleaning device using air and water flow for endoscopic surgery
por: Tatsuki, Hironori, et al.
Publicado: (2018)

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
por: Ismaili, Nabil, et al.
Publicado: (2009)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
por: Yin, Yuanxiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8ti7e0q0bqc772n2srgf381u0